Clinical Trial Update: Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study of levetiracetam in pediatric epilepsy patients aged 1 month to under 4 years completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 2 | Status: COMPLETED